These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25415524)

  • 1. Methotrexate treatment in myasthenia gravis.
    Karaahmet OZ; Bal A; Dulgeroglu D; Bahceci HK; Cakcı A
    J Clin Neuromuscul Dis; 2014 Dec; 16(2):106-7. PubMed ID: 25415524
    [No Abstract]   [Full Text] [Related]  

  • 2. Improvement with rituximab in a patient with both rheumatoid arthritis and myasthenia gravis.
    Kerkeni S; Marotte H; Miossec P
    Muscle Nerve; 2008 Oct; 38(4):1343-5. PubMed ID: 18816604
    [No Abstract]   [Full Text] [Related]  

  • 3. Rheumatoid arthritis and ocular myasthenia gravis: Effectiveness of rituximab in the management of these two diseases.
    Novella-Navarro M; Salvatierra-Ossorio J; Muñoz-Gómez MDM; Pavo-Blanco M
    Reumatol Clin (Engl Ed); 2018; 14(3):179-180. PubMed ID: 28624374
    [No Abstract]   [Full Text] [Related]  

  • 4. Rheumatoid arthritis and myasthenia gravis: a case-based review of the therapeutic options.
    Bixio R; Bertelle D; Pistillo F; Pedrollo E; Carletto A; Rossini M; Viapiana O
    Clin Rheumatol; 2022 Apr; 41(4):1247-1254. PubMed ID: 35031874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myasthenia gravis, rheumatoid arthritis, vitiligo, and autoimmune haemolytic anaemia.
    Durance RA; Hamilton EB
    Proc R Soc Med; 1971 Jan; 64(1):61-2. PubMed ID: 5551461
    [No Abstract]   [Full Text] [Related]  

  • 6. The treatment of severe myasthenia gravis with immunosuppressive agents.
    Mertens HG; Balzereit F; Leipert M
    Eur Neurol; 1969; 2(6):321-39. PubMed ID: 4185500
    [No Abstract]   [Full Text] [Related]  

  • 7. Primary CNS lymphoma in myasthenic on long-term azathioprine.
    Finelli PF
    J Neurooncol; 2005 Aug; 74(1):91-2. PubMed ID: 16078114
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunosuppressive drugs in treatment of myasthenia gravis.
    Rowland LP
    Ann N Y Acad Sci; 1971 Sep; 183():351-7. PubMed ID: 5287832
    [No Abstract]   [Full Text] [Related]  

  • 9. [Heart disease in myasthenia gravis].
    Mygland A; Gilhus NE; Hofstad H; Aarli JA; Thunold S
    Tidsskr Nor Laegeforen; 1990 Apr; 110(10):1209-11. PubMed ID: 2333646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate and methotrexate are better tolerated than azathioprine in myasthenia gravis.
    Dodd KC; Ahmed R; Ambrose P; Holt JK; Jacob S; Leite MI; Miller JA; San PP; Spillane J; Viegas S; Sussman J
    Neuromuscul Disord; 2024 May; 38():51-57. PubMed ID: 38626662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive therapy of myasthenia gravis.
    Szobor A; Petrányi G
    Acta Med Acad Sci Hung; 1970; 27(4):397-411. PubMed ID: 5314027
    [No Abstract]   [Full Text] [Related]  

  • 12. [A case of myasthenia gravis following sarcoidosis and rheumatoid arthritis].
    Sawada J; Asanome A; Endo H; Saito T; Katayama T; Hasebe N
    Rinsho Shinkeigaku; 2013; 53(5):351-5. PubMed ID: 23719982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The association of myasthenia and disseminated lupus erythematosus. 2 cases].
    Schoenen J; Delwaide PJ
    Nouv Presse Med; 1976 May; 5(18):1185-8. PubMed ID: 775436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current results of the treatment of pseudoparalytic myasthenia gravis with immunosuppressive agents].
    Ricken D
    Monatsschr Kinderheilkd (1902); 1972 Jun; 120(6):237-41. PubMed ID: 4341360
    [No Abstract]   [Full Text] [Related]  

  • 15. Penicillamine-induced ocular myasthenia gravis in rheumatoid arthritis.
    Liu GT; Bienfang DC
    J Clin Neuroophthalmol; 1990 Sep; 10(3):201-5. PubMed ID: 2144538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial concurrence of myasthenia gravis and rheumatoid arthritis.
    Namba T; Grob D
    Arch Intern Med; 1970 Jun; 125(6):1056-8. PubMed ID: 4951934
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunosuppressive treatment in neurological disorders].
    Aarli JA
    Tidsskr Nor Laegeforen; 1973 Jun; 93(18):1395-7. PubMed ID: 4356438
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase II trial of methotrexate in myasthenia gravis.
    Pasnoor M; He J; Herbelin L; Dimachkie M; Barohn RJ;
    Ann N Y Acad Sci; 2012 Dec; 1275(1):23-8. PubMed ID: 23278574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of myasthenia gravis pseudoparalytica].
    Rüster M; Dietel K
    Kinderarztl Prax; 1970 Jul; 38(7):309-12. PubMed ID: 5523869
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies in bullous diseases: treatment of pemphigus vulgaris with methotrexate, two patients (one with concurrent myasthenia gravis).
    Peck SM; Osserman KE
    J Mt Sinai Hosp N Y; 1969; 36(1):71-6. PubMed ID: 5249498
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.